<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Israel</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Israel.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/il.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Acute hepatitis B in the vaccination era: Predictors of functional cure and chronicity</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4254-wjh-124108-0496c536/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4254-wjh-124108-0496c536/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest acute HBV infection in the vaccination era carries higher-than-expected chronicity risk, particularly among patients with metabolic disease and socioeconomic disadvantage. This supports the need for early risk stratification and targeted follow-up for vulnerable populations despite vaccine availability.</description>
    <category>Acute hepatitis B</category>
    <category>Hepatitis B</category>
    <category>Hepatitis D</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Comparator-Dependent Safety Signals for Incident Systemic Autoimmune Rheumatic Diseases After mRNA COVID-19 Vaccination: A Systematic Review</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080706-9ff137c3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080706-9ff137c3/</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesis addresses ongoing clinical uncertainty regarding potential autoimmune complications following widespread mRNA immunization campaigns. Identifying the gap in extended monitoring frameworks underscores the necessity for sustained epidemiological tracking beyond immediate post-vaccination periods.</description>
    <category>COVID-19</category>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Salmonella and Salmonellosis in Wild Birds</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-ani14233533-6e99aaa5/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-ani14233533-6e99aaa5/</guid>
    <pubDate>Fri, 06 Dec 2024 00:00:00 GMT</pubDate>
    <description>Birds may transmit Salmonella to humans directly through fecal contact or indirectly via contamination of foods such as peanut butter. Fecal material on bird feeders and tables represents a contact risk requiring precautionary hygiene measures.</description>
    <category>Salmonellosis</category>
    <category>Transmission dynamics</category>
    <category>One Health</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Monkeypox outbreak in the Tel Aviv District, Israel, 2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2022-12-023-5071231c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2022-12-023-5071231c/</guid>
    <pubDate>Wed, 01 Mar 2023 00:00:00 GMT</pubDate>
    <description>The report underscores the operational value of targeted immunization strategies for vulnerable demographics and emphasizes continuous monitoring to mitigate future regional spread.</description>
    <category>Monkeypox</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2022-05-022-97a8b288/</guid>
    <pubDate>Fri, 01 Jul 2022 00:00:00 GMT</pubDate>
    <description>The registry addresses a recognized barrier in pandemic response by providing a centralized infrastructure to accelerate clinical trial recruitment across European countries, potentially shortening the timeline for vaccine and treatment development during infectious disease outbreaks.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Waning Immunity after the BNT162b2 Vaccine in Israel</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa2114228-d260af0d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa2114228-d260af0d/</guid>
    <pubDate>Thu, 09 Dec 2021 00:00:00 GMT</pubDate>
    <description>The findings suggest that vaccine-induced protection against delta variant infection and severe disease diminished within months of the second dose, which has implications for booster dose timing and outbreak control strategies.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Brucellosis Outbreak Traced to Commercially Sold Camel Milk through Whole-Genome Sequencing, Israel</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2706-204902-f7876323/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2706-204902-f7876323/</guid>
    <pubDate>Tue, 01 Jun 2021 00:00:00 GMT</pubDate>
    <description>Brucellosis remains a globally relevant zoonosis acquired from contaminated food. The report highlights risks posed by unregulated commercial raw-milk distribution and underscores the value of genomic methods for tracing outbreaks to specific agricultural supply chains.</description>
    <category>Brucellosis</category>
    <category>Outbreak investigation</category>
    <category>Treatment</category>
    <category>Genomic epidemiology</category>
    <category>One Health</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-19-30297-x-692c94da/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s1473-3099-19-30297-x-692c94da/</guid>
    <pubDate>Mon, 01 Jul 2019 00:00:00 GMT</pubDate>
    <description>Findings suggest emerging non-vaccine serotypes may be shaped by local antibiotic-selective pressures, highlighting the need for continued genomic surveillance to inform future vaccine design.</description>
    <category>Invasive pneumococcal disease</category>
    <category>Genomic epidemiology</category>
    <category>Antimicrobial resistance</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>A Large Outbreak of Salmonella Paratyphi A Infection Among Israeli Travelers To Nepal</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-cit723-b312034a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-cit723-b312034a/</guid>
    <pubDate>Tue, 05 Nov 2013 00:00:00 GMT</pubDate>
    <description>The outbreak highlights the risk of paratyphoid fever among travelers to endemic areas in Asia and suggests that combination antibiotic therapy may improve clinical outcomes. The point-source nature and nalidixic acid resistance pattern have implications for travel medicine and outbreak response.</description>
    <category>Paratyphoid fever</category>
    <category>Treatment</category>
    <category>Travel medicine</category>
    <category>Outbreak investigation</category>
    <category>Outbreak investigation</category>
  </item>
</channel>
</rss>
